No Prescription |
 |
 | ||
|
A RET Vesanoid |
|
| ||
No Prescription » Prescription Drugs 1 » A RET Vesanoid This medication is used to improve the appearance of the skin by reducing fine lines and wrinkles reducing roughness and improving skin color. It should be used with a skin care and sunlight-avoidance program that includes moisturizer and daily use of an effective sunscreen (minimum SPF 15).Tretinoin belongs to a class of medications called retinoids. It works by affecting the growth of skin cells. Tretinoin does not repair sun-damaged skin or reverse aging due to sun exposure.OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.Your doctor may use this medication to treat other skin conditions including acne.How to use Tretinoin (Emollient) TopRead the Patient Information Leaflet available from your pharmacist before you start using this medication and each time you get a refill. Ask your doctor or pharmacist if you have any questions.Gently clean your face with a mild or soapless cleanser and pat skin dry. Wait 20-30 minutes before applying this medication. Apply a pea-sized amount of cream using just enough to cover your entire face lightly usually once a day before bedtime or as directed by your doctor. Be careful to avoid your eyes nostrils and mouth. Do not wash your face or apply another skin care product for at least 1 hour after using this product.Do not use more of this medication than prescribed or use in larger amounts. It will not give you faster or better results but will increase the risk of developing redness peeling and pain. Do not use on cut scraped sunburned or eczema-affected skin.Avoid getting this medication in your eyes. If this medication gets into your eyes flush with large amounts of water. Call your doctor if eye irritation develops. Wash your hands after using the medication to avoid accidentally getting it in your eyes.Effects of this medication will appear slowly with most improvement seen in the first 6 months of use.If used for acne your condition may worsen at first then improve.Tretinoin (Emollient) Top is used to treat the following:Fine Wrinkling of the Face Thickening of the Outer Horny Layer of the Skin Fine Wrinkling Varying Shades of Excessive Coloration of a Body Part Buy A RET Vesanoid and other Prescription Drugs 1 products online at Medstore. Buy Online at Medstore - Click Here!
About A RET Vesanoid: Product Type: Prescription Drugs 1 A-RET ( Vesanoid Avita Renova Retin-A Generic Tretinoin ) A-RET (Vesanoid Avita Renova Retin-A Generic Tretinoin) Vesanoid Avita Renova Retin-A Generic Tretinoin Gel 0.025% 20gm Gel 0.1% 40gm (2 x 20gm) Vesanoid Avita Renova Retin-A Generic Tretinoin A-RET
View more Prescription Drugs 1 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
